Natco Pharma is a well-known name in the pharmaceutical industry, recognized for its strong presence in the generic and specialty drug market. Investors are keen to know its future potential, as the company continues to expand in domestic and international markets. Factors like research and development, regulatory approvals, and market demand play a key role in determining its share price growth. Natco Pharma Share Price on 31 March 2025 is 799.85 INR. This article will provide more details on Natco Pharma Share Price Target 2025, 2026 to 2030.
Natco Pharma Company Info
- Headquarters: Banjara Hills, Hyderabad
- Number of employees: 4,016 (2024)
- Revenue: 2,811 crores INR (US$350 million, FY23)
- Subsidiaries: Dash Pharmaceuticals LLC.
Natco Pharma Share Price Chart
Natco Pharma Share Price Details
- Today Open: 822.85
- Today High: 834.95
- Today Low: 795.00
- Mkt cap: 14.29KCr
- P/E ratio: 7.68
- Div yield: 0.75%
- 52-wk high: 1,639.00
- 52-wk low: 757.05
Natco Pharma Shareholding Pattern
- Promoters: 49.62%
- Foreign Institutions: 17.94%
- Mutual Funds: 1.92%
- Retails and others: 26.87%
- Domestic Institutions: 3.66%
Natco Pharma Share Price Target Tomorrow 2025, 2026 To 2030
- 2025 – ₹1640
- 2026 – ₹1800
- 2027 – ₹1950
- 2028 – ₹2000
- 2029 – ₹2150
- 2030 – ₹2300
Natco Pharma Share Price Target 2025
Natco Pharma share price target 2025 Expected target could be ₹1640. Here are 5 Key Factors Affecting Growth for Natco Pharma Share Price Target 2025:
-
Expansion in Domestic & International Markets – Natco Pharma’s ability to strengthen its presence in key markets like the U.S., India, and other emerging countries will play a crucial role in its revenue growth.
-
New Drug Launches & Approvals – The company’s pipeline of generic and specialty drugs, along with timely approvals from regulatory bodies like the FDA, will significantly impact its stock performance.
-
Demand for Oncology & Specialty Medicines – Natco Pharma has a strong focus on oncology and niche therapeutics. Growing demand for these treatments can drive higher sales and profitability.
-
Patent Challenges & Litigation Outcomes – Success in challenging patents and launching first-to-market generics can boost revenue, while legal setbacks may pose risks to its growth.
-
Financial Performance & Cost Management – A strong balance sheet, efficient cost control, and steady revenue growth will enhance investor confidence and support positive stock movement.
Natco Pharma Share Price Target 2030
Natco Pharma share price target 2030 Expected target could be ₹2300. Here are 5 Key Factors Affecting Growth for Natco Pharma Share Price Target 2030:
-
Long-Term Expansion in Global Markets – Natco Pharma’s sustained growth will depend on its ability to expand in major markets like the U.S., Europe, and emerging economies, ensuring steady revenue streams.
-
Innovation & R&D Investments – Increased spending on research and development for high-margin specialty drugs, biosimilars, and complex generics will drive future growth and competitive advantage.
-
Regulatory Approvals & Compliance – Securing approvals from global regulatory bodies, such as the U.S. FDA and EMA, for new drug formulations and maintaining compliance standards will be key to uninterrupted growth.
-
Strategic Partnerships & Acquisitions – Collaborations with global pharmaceutical firms and potential mergers or acquisitions can strengthen Natco Pharma’s market position and open new revenue opportunities.
-
Evolving Healthcare Trends & Drug Demand – Growing demand for specialized treatments, increased healthcare spending, and advancements in pharmaceuticals will shape the long-term profitability and stock valuation of the company.
Financial Statement Of Natco Pharma
| (INR) | 2024 | Y/Y change |
| Revenue | 40.02B | 47.76% |
| Operating expense | 16.83B | 35.23% |
| Net income | 13.88B | 94.09% |
| Net profit margin | 34.69 | 31.35% |
| Earnings per share | 77.34 | 97.40% |
| EBITDA | 17.51B | 81.05% |
| Effective tax rate | 17.04% | — |
Read Also:- PG Share Price Target Tomorrow 2025, 2026 To 2030